NEW YORK (360Dx) – The World Health Organization said this week that it is extending its European Laboratory Initiative on TB to include HIV and viral hepatitis. The WHO said it aims to more effectively address the specific needs of the European region with the inclusion of the two diseases and added that Europe is the only WHO region where HIV infections and tuberculosis/HIV co-infections are rising because of late HIV diagnoses. Rates of multidrug-resistant TB also are high, and viral hepatitis has a low diagnosis rate, making it a major public health threat, the WHO said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.